How PDE/HBEL values are integrated with exposure, process and control information in pharmaceutical Quality Risk Management.
Quality Risk Management connects toxicological hazard with the probability and magnitude of exposure. The HBEL provides a quantitative anchor for the hazard dimension but does not replace the process-specific assessment.
Hazard and exposure
Risk arises from the interaction between the harmful properties of a substance and the opportunity for exposure.
Process-specific context
Equipment design, material flow, airborne transfer, cleaning, campaign strategy and analytical capability can change the practical risk.
Proportionality
ICH Q9(R1) expects the level of effort, formality and documentation to be commensurate with risk.
Lifecycle
New products, process changes, equipment changes and new toxicological data can require reassessment.
Frequently asked questions
Can the same HBEL lead to different controls in two plants?
Yes. Exposure pathways and process controls can differ.
Does QRM require one specific tool?
No. The tool should be appropriate to the problem and level of risk.
Should risk assessment be updated?
Yes, when new information or changes alter the original assumptions.
Can a risk score replace expert judgment?
No. Scoring tools support but do not replace scientific and process expertise.
